Source-grounded facts extracted from Vyome Holdings, Inc's SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Paul F. Hickey was appointed as President and Chief Executive Officer at Vyome Holdings, Inc.
“On July 27, 2022, ReShape Lifesciences Inc. (the “Company”) announced that its Board of Directors has appointed Paul F. Hickey as President and Chief Executive Officer and as a member of the Board of Directors, effective August 15, 2022.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.